Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000421580 | SCV000528580 | likely benign | not provided | 2020-04-03 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV000653329 | SCV000775208 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2023-10-10 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000421580 | SCV001143341 | likely benign | not provided | 2019-05-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002521817 | SCV003699585 | likely benign | Inborn genetic diseases | 2021-07-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |